Medicaid Medication Risk Reduction Initiative

The New Hampshire Department of Health and Human Services, Division of Medicaid Services, is soliciting proposals to establish a statewide Medicaid Medication Risk Reduction Initiative (MMRRI). This program, which will be led by New Hampshire licensed clinical pharmacists, aims to prevent and reduce medication-related problems, adverse drug events, polypharmacy, over-prescribing, and medication risks associated with opioids and behavioral health for Medicaid beneficiaries. Key deliverables include the implementation of a technology solution to analyze pharmacy claims data, the performance of comprehensive medication reviews for high-risk individuals, and the generation of actionable medication safety reports for patients and providers. The anticipated total contract value is 33,553,391 dollars, funded through the Rural Health Transformation Program (RHTP) using federal funds. The period of performance extends through October 30, 2030, with a structured schedule of annual progress reports. Award selection is based on a point system evaluating technical and cost responses, requiring a minimum technical score of 1,600 points to avoid disqualification. The contract includes strict compliance mandates, including 2 CFR Part 200, Title VI of the Civil Rights Act, and ADA requirements, as well as financial at-risk terms such as liquidated damages equivalent to 10 percent of the yearly contract value to enforce per member per month reduction guarantees. Qualified vendors must possess at least three years of experience in pharmacy data analysis and medication review. Proposals must be submitted as two separate electronic documents consisting of a technical response and a cost proposal by October 28, 2026. The selected contractor must maintain a robust Information Security Management System compliant with New Hampshire Department Information Technology policies to protect sensitive health data, with all information processing required to remain within the United States.